Ha habido 50 transacciones internas recientes registradas para Incyte Corporation (INCY), incluyendo 16 compras y 33 ventas. El total de compras internas fue valorado en $8.39M y el total de ventas internas en $37.61M.
Internos destacados con actividad reciente incluyen Harrigan Edmund, Baker Bros. Advisors Lp, Clancy Paul J. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — INCY
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-31 |
Harrigan Edmund |
Director |
Concesión de RSU |
269 |
$94.12 |
$25.32K |
21,122 |
| 2026-03-31 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Concesión de RSU |
421 |
- |
- |
2,818,039 |
| 2026-03-31 |
Clancy Paul J |
Director |
Concesión de RSU |
265 |
$94.12 |
$24.94K |
23,741 |
| 2026-03-25 |
Trotta Matteo |
EVP, GM, Dermatology Us |
Retención Fiscal de RSU |
537 |
$92.23 |
$49.53K |
14,882 |
| 2026-03-17 |
Cagnoni Pablo J |
President, R&d |
Ejercicio de Opciones (Venta) |
7,166 |
$61.18 |
$438.42K |
9,102 |
| 2026-02-19 |
Cagnoni Pablo J |
President, R&d |
Ejercicio de Opciones (Venta) |
13,093 |
$61.76 |
$808.62K |
7,182 |
| 2026-02-02 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Retención Fiscal de RSU |
185 |
$102.67 |
$18.99K |
34,065 |
| 2026-02-02 |
Heeson Lee |
EVP, Head of Incyte Intl |
Retención Fiscal de RSU |
111 |
$102.67 |
$11.4K |
38,041 |
| 2026-01-20 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Retención Fiscal de RSU |
429 |
$102.62 |
$44.02K |
34,250 |
| 2026-01-16 |
Cagnoni Pablo J |
President, R&d |
Concesión de RSU |
28,475 |
$106.21 |
$3.02M |
28,475 |
| 2026-01-16 |
Stein Steven H |
EVP & Chief Medical Officer |
Concesión de RSU |
19,932 |
$106.21 |
$2.12M |
19,932 |
| 2026-01-16 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Concesión de RSU |
7,426 |
- |
- |
34,679 |
| 2026-01-16 |
Tray Thomas |
Principal Accounting Officer |
Concesión de RSU |
2,425 |
$106.21 |
$257.56K |
2,425 |
| 2026-01-16 |
Trotta Matteo |
EVP, GM, Dermatology Us |
Concesión de RSU |
8,542 |
$106.21 |
$907.25K |
8,542 |
| 2026-01-16 |
Heeson Lee |
EVP, Head of Incyte Intl |
Concesión de RSU |
8,911 |
- |
- |
38,152 |
| 2026-01-16 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
Concesión de RSU |
14,237 |
$106.21 |
$1.51M |
14,237 |
| 2026-01-16 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
Concesión de RSU |
4,218 |
$106.21 |
$447.99K |
4,218 |
| 2026-01-07 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
Venta Informativa |
10,856 |
$109.07 |
$1.18M |
66,132 |
| 2026-01-06 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
Retención Fiscal de RSU |
8,264 |
$106.66 |
$881.44K |
76,988 |
| 2026-01-05 |
Stein Steven H |
EVP & Chief Medical Officer |
Venta Informativa |
15,634 |
$101.70 |
$1.59M |
34,203 |
| 2025-12-31 |
Harrigan Edmund |
Director |
Concesión de RSU |
245 |
$98.77 |
$24.2K |
20,853 |
| 2025-12-31 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Concesión de RSU |
328 |
- |
- |
2,817,618 |
| 2025-12-31 |
Clancy Paul J |
Director |
Concesión de RSU |
241 |
$98.77 |
$23.8K |
23,476 |
| 2025-12-31 |
Stein Steven H |
EVP & Chief Medical Officer |
Retención Fiscal de RSU |
13,292 |
$98.77 |
$1.31M |
49,837 |
| 2025-12-31 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Retención Fiscal de RSU |
254 |
$98.77 |
$25.09K |
27,253 |
| 2025-12-19 |
Tray Thomas |
Principal Accounting Officer |
Ejercicio de Opciones (Venta) |
1,044 |
$95.76 |
$99.97K |
- |
| 2025-12-18 |
Tray Thomas |
Principal Accounting Officer |
Venta Informativa |
600 |
$98.25 |
$58.95K |
22,973 |
| 2025-12-17 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Venta Informativa |
4,323 |
$97.26 |
$420.45K |
27,507 |
| 2025-12-16 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Venta Informativa |
53,175 |
$97.29 |
$5.17M |
31,830 |
| 2025-12-11 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
Venta Informativa |
255 |
$94.94 |
$24.21K |
60,011 |
| 2025-12-10 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
Venta Informativa |
5,553 |
$95.58 |
$530.76K |
60,266 |
| 2025-12-08 |
Hoppenot Herve |
Director |
Retención Fiscal de RSU |
2,843 |
$96.70 |
$274.92K |
326,803 |
| 2025-12-02 |
Stein Steven H |
EVP & Chief Medical Officer |
Venta Informativa |
20,105 |
$102.51 |
$2.06M |
63,129 |
| 2025-12-01 |
Stein Steven H |
EVP & Chief Medical Officer |
Retención Fiscal de RSU |
17,093 |
$102.04 |
$1.74M |
83,234 |
| 2025-12-01 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Retención Fiscal de RSU |
326 |
$102.04 |
$33.27K |
85,838 |
| 2025-12-01 |
Hoffman Richard A. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-12-01 |
Hoffman Richard A. |
EVP & General Counsel |
Concesión de RSU |
9,466 |
- |
- |
9,466 |
| 2025-11-24 |
Tray Thomas |
Principal Accounting Officer |
Venta Informativa |
600 |
$103.00 |
$61.8K |
23,573 |
| 2025-11-21 |
Tray Thomas |
Principal Accounting Officer |
Venta Informativa |
169 |
$102.00 |
$17.24K |
24,173 |
| 2025-11-17 |
Denton Sheila A. |
EVP & General Counsel |
Ejercicio de Opciones (Venta) |
278 |
$64.25 |
$17.86K |
8,883 |
| 2025-11-10 |
Hoppenot Herve |
Director |
Venta Informativa |
187,500 |
$105.46 |
$19.77M |
329,646 |
| 2025-11-05 |
Stein Steven H |
EVP & Chief Medical Officer |
Ejercicio de Opciones (Venta) |
1,194 |
$83.83 |
$100.09K |
- |
| 2025-11-04 |
Denton Sheila A. |
EVP & General Counsel |
Ejercicio de Opciones (Venta) |
598 |
$58.06 |
$34.72K |
13,765 |
| 2025-11-03 |
Heeson Lee |
EVP, Head of Incyte Intl |
Venta Informativa |
3,074 |
$94.02 |
$289.02K |
29,241 |
| 2025-10-15 |
Denton Sheila A. |
EVP & General Counsel |
Ejercicio de Opciones (Venta) |
277 |
$64.25 |
$17.8K |
9,161 |
| 2025-10-03 |
Denton Sheila A. |
EVP & General Counsel |
Venta Informativa |
3,501 |
$85.54 |
$299.48K |
26,569 |
| 2025-10-02 |
Denton Sheila A. |
EVP & General Counsel |
Ejercicio de Opciones (Venta) |
599 |
$58.06 |
$34.78K |
14,363 |
| 2025-10-01 |
Heeson Lee |
EVP, Head of Incyte Intl |
Retención Fiscal de RSU |
463 |
$86.70 |
$40.14K |
32,315 |
| 2025-10-01 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
Retención Fiscal de RSU |
1,569 |
$86.70 |
$136.03K |
65,819 |
| 2025-09-30 |
Harrigan Edmund |
Director |
Concesión de RSU |
289 |
$84.81 |
$24.51K |
20,608 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
